Efficacy, safety and pharmacokinetics of indacaterol acetate in patients with persistent asthma

Update Il y a 4 ans
Reference: EUCTR2012-000520-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate superiority of indacaterol acetate 75 or 150 μg to placebo with respect to 24 h postdose trough FEV1 after 12 weeks of treatment in patient with persistent asthma.


Inclusion criteria

  • Asthma